Your session is about to expire
← Back to Search
Incentives & Motivation for Behavior Change
N/A
Waitlist Available
Led By Jessica Fishman, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the duration of the experiment: less than 1 day
Awards & highlights
Study Summary
This trial is designed to see if different ways of presenting information about vaccines affects people's decisions to get vaccinated, and to understand how different types of incentives (financial or social) play a role in that decision. The trial will compare different methods of measuring people's intention to vaccinate, and will also test different vaccine policies to see what effect they have on people's decisions.
Eligible Conditions
- Behavior
- Intention
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through the duration of the experiment: less than 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the duration of the experiment: less than 1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
measure of decision (vaccine intention)
measure of whether they are interested in RCT enrollment (for sleep or exercise)
Secondary outcome measures
likelihood of behavior
Trial Design
14Treatment groups
Experimental Treatment
Group I: specific vaccine policy 9Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group II: specific vaccine policy 8Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group III: specific vaccine policy 7Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group IV: specific vaccine policy 6Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group V: specific vaccine policy 5Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group VI: specific vaccine policy 3Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group VII: specific vaccine policy 2Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group VIII: specific vaccine policy 10Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group IX: specific vaccine policy 1Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Group X: sleep social incentiveExperimental Treatment1 Intervention
Those in this arm will invite adults to join an RCT that uses social (gamification) incentives to reward those who increase their sleep.
Group XI: sleep financial incentiveExperimental Treatment1 Intervention
Those in this arm will invite adults to join an RCT that uses financial incentives to reward those who increase their sleep.
Group XII: exercise social incentiveExperimental Treatment1 Intervention
Those in this arm will invite adults to join an RCT that uses social incentives to reward those who increase their exercise.
Group XIII: exercise financial incentiveExperimental Treatment1 Intervention
Those in this arm will invite adults to join an RCT that uses financial incentives to reward those who increase their exercise.
Group XIV: Specific vaccine policy 4Experimental Treatment1 Intervention
Those in this arm will learn about a specific financial incentive or mandate policy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
incentive lottery medium
2021
N/A
~4000
invitation for exercise social incentive study
2021
N/A
~4000
invitation for exercise financial incentive study
2021
N/A
~4000
cash large
2021
N/A
~4000
cash small
2021
N/A
~4000
cash medium
2021
N/A
~4000
invitation for sleep social incentive study
2021
N/A
~4000
invitation for sleep financial incentive
2021
N/A
~4000
incentive lottery large
2021
N/A
~4000
mandate public
2021
N/A
~4000
employer mandate
2021
N/A
~4000
incentive reward
2021
N/A
~4000
penalty
2021
N/A
~4000
incentive lottery small
2021
N/A
~4000
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,878,209 Total Patients Enrolled
Jessica Fishman, PhDPrincipal InvestigatorUniversity of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be up to date on your vaccinations.You have not received the COVID-19 vaccine.The study does not accept children as participants.
Research Study Groups:
This trial has the following groups:- Group 1: exercise social incentive
- Group 2: specific vaccine policy 5
- Group 3: specific vaccine policy 6
- Group 4: sleep financial incentive
- Group 5: sleep social incentive
- Group 6: exercise financial incentive
- Group 7: specific vaccine policy 7
- Group 8: specific vaccine policy 8
- Group 9: specific vaccine policy 9
- Group 10: specific vaccine policy 10
- Group 11: specific vaccine policy 1
- Group 12: specific vaccine policy 2
- Group 13: specific vaccine policy 3
- Group 14: Specific vaccine policy 4
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger